Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
about
Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic DeliveryCell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer CellsDevelopment of bimolecular fluorescence complementation using rsEGFP2 for detection and super-resolution imaging of protein-protein interactions in live cells.The role of individual caspases in cell death induction by taxanes in breast cancer cells.Usefulness of monitoring γ-H2AX and cell cycle arrest in HepG2 cells for estimating genotoxicity using a high-content analysis system.pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft modelA Single-Cell Assay for Time Lapse Studies of Exosome Secretion and Cell Behaviors.Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning.Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy.ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.Enhancing the Apoptotic Effect of a Low Dose of Paclitaxel on Tumor Cells in Mice by Arabinoxylan Rice Bran (MGN-3/Biobran).Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancerFunctional inhibition of aquaporin-3 with a gold-based compound induces blockage of cell proliferation.Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts.Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer.
P2860
Q28087367-C2ECF14F-CEA7-42AD-A298-512CD2E9B618Q28553956-CE85D72E-63FC-4E67-8CED-E07EB2789F0DQ33824525-C10F0626-DF25-4EAB-8394-4CFFE9AACA40Q35085574-89EB00D3-6FA4-4195-904C-8D32E2C4640DQ35198605-5C7F8A1A-0D6D-406E-8306-CA3903C2738CQ36794562-B9DA44A2-ABCC-4A31-92B0-B27EC6849EA2Q37256232-708817BB-42D6-49F3-AC5C-394BCF68D3AEQ38835169-58D0190E-91CF-4F30-8BC7-E1AD1C6F9B30Q38997446-ED3D441D-EBA7-4319-BFBA-7DFDC8ABBCB1Q39226312-FCA3C634-7134-43E9-A42E-94275691EC4EQ39639123-7C8601D8-72D0-46BF-BF0C-5A0EB0E10FC5Q42274998-1767ADAF-C6A0-4FA0-B94A-A120C1FE01D8Q42804857-43AAEADE-B420-4077-B2E0-47C675D427B5Q46603509-118153AA-D112-4126-818C-3C07EFA9A575Q50675888-69A60ADE-02D6-4A06-8938-D60B79F8D20D
P2860
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Paclitaxel sensitivity of brea ...... ion of Bcl-xL/Bak interaction.
@en
Paclitaxel sensitivity of brea ...... ion of Bcl-xL/Bak interaction.
@nl
type
label
Paclitaxel sensitivity of brea ...... ion of Bcl-xL/Bak interaction.
@en
Paclitaxel sensitivity of brea ...... ion of Bcl-xL/Bak interaction.
@nl
prefLabel
Paclitaxel sensitivity of brea ...... ion of Bcl-xL/Bak interaction.
@en
Paclitaxel sensitivity of brea ...... ion of Bcl-xL/Bak interaction.
@nl
P2093
P2860
P1476
Paclitaxel sensitivity of brea ...... tion of Bcl-xL/Bak interaction
@en
P2093
Carolina Castilla
M Luz Flores
Manuel Ruiz-Borrego
Rainiero Ávila
P2860
P2888
P304
P356
10.1007/S10549-011-1864-9
P407
P577
2011-11-11T00:00:00Z